Tag: Pharmadrug - Psychedelic Alpha

Access exclusive insights, data and interviews with Pα+: learn more and subscribe today.

Read more about the article PharmaDrug Receives Positive Results for DMT-Analogue Program to Treat Glaucoma

PharmaDrug Receives Positive Results for DMT-Analogue Program to Treat Glaucoma

Post published:February 23, 2022
Post category:Press Release

Read more about the article PharmaDrug Announces Initiation of Manufacturing of Cepharanthine (PD-001) For Clinical Programs in Rare Cancers And COVID-19

PharmaDrug Announces Initiation of Manufacturing of Cepharanthine (PD-001) For Clinical Programs in Rare Cancers And COVID-19

Post published:January 26, 2022
Post category:Press Release

Read more about the article PharmaDrug Engages Octagon Media and Affiliated Wall Street Reporter for Investor Marketing Campaign

PharmaDrug Engages Octagon Media and Affiliated Wall Street Reporter for Investor Marketing Campaign

Post published:January 20, 2022
Post category:Press Release

Read more about the article PharmaDrug Announces Resignation of Director

PharmaDrug Announces Resignation of Director

Post published:January 13, 2022
Post category:Press Release

Read more about the article PharmaDrug Announces Addition of Dr. Cindy Hutnik, President of the Canadian Glaucoma Society to Their Scientific Advisory Board to Enhance Ongoing DMT Studies to Treat Glaucoma

PharmaDrug Announces Addition of Dr. Cindy Hutnik, President of the Canadian Glaucoma Society to Their Scientific Advisory Board to Enhance Ongoing DMT Studies to Treat Glaucoma

Post published:December 13, 2021
Post category:Press Release

Read more about the article PharmaDrug Advances Psychedelics Program with Analogue DMT Formulations to Treat Eye Diseases

PharmaDrug Advances Psychedelics Program with Analogue DMT Formulations to Treat Eye Diseases

Post published:November 5, 2021
Post category:Press Release

Read more about the article PharmaDrug Expands Product Offering to Prepare for Potential Adult Use Market in Germany

PharmaDrug Expands Product Offering to Prepare for Potential Adult Use Market in Germany

Post published:November 1, 2021
Post category:Press Release

Read more about the article Biotech Veteran David Kideckel Joins the Board of PharmaDrug

Biotech Veteran David Kideckel Joins the Board of PharmaDrug

Post published:August 30, 2021
Post category:Press Release

Read more about the article PharmaDrug Announces Clinical Research Collaboration with The Johns Hopkins University to Evaluate DMT in a Comparative Clinical Study

PharmaDrug Announces Clinical Research Collaboration with The Johns Hopkins University to Evaluate DMT in a Comparative Clinical Study

Post published:August 25, 2021
Post category:Press Release

Read more about the article PharmaDrug Forms Research Collaboration with Terasaki Institute for Novel Ocular Drug Formulation Program to Deliver DMT and Other Tryptamines to Treat Eye Disease

PharmaDrug Forms Research Collaboration with Terasaki Institute for Novel Ocular Drug Formulation Program to Deliver DMT and Other Tryptamines to Treat Eye Disease

Post published:August 5, 2021
Post category:Press Release

End of content

No more pages to load

Psychedelic Alpha

Psychedelic Alpha is an independent newsletter and community that strives to empower a diverse constellation of individuals and organisations with the knowledge, network and nuance to make an impact within the field of psychedelic medicine and beyond

Quick Links

Newsletter

Insights and interviews delivered to your inbox. No spam, just valuable information.